Provider Reviews

IVIM Health vs He & She MD: GLP-1 Program Comparison

Quick verdict: IVIM Health is strongest on third-party ratings and a free no-obligation consultation plus a free month code, while He & She MD emphasizes bundled coaching, 1:1 clinician messaging and six-month promotional pricing. This piece compares IVIM Health vs He & She MD on the differences that matter.

Head-to-head summary: ratings, support, price structure

Comparing IVIM Health vs He & She MD directly, three key differences stand out from the supplied evidence: third-party ratings and trust signals, the scope of bundled coaching and clinician access, and how pricing and promotional terms are structured and presented.

1. Third-party ratings and trust signals

IVIM Health is described as having an unusually strong third-party signal: a 4.9-star rating on both Google and Trustpilot. The source frames that dual 4.9-star rating as a rare verification in the market. He & She MD does not have a comparable dual third-party rating cited in the provided evidence; its selling points focus on app-based coaching and clinician messaging instead.

2. Coaching, clinician access, and program support

He & She MD bundles a coaching app with 1:1 clinician messaging, GLP-1-specific guidance and progress tracking at no extra cost. The source says every plan includes those app features and free expedited shipping and that the app and messaging are built into the plan rather than sold separately. IVIM Health emphasizes a clinician-guided proprietary GLP-1 ID protocol and structured titration, but the supplied evidence does not describe an equivalent built-in app with 1:1 messaging.

3. Pricing format and promotional terms

IVIM Health lists specific monthly medication prices and a program fee: examples include Semaglutide (compounded) at $75/mo, Tirzepatide (compounded) at $133/mo, plus a $74.99/mo program fee; IVIM also advertises a no-obligation free consultation worth $75 and a free month membership code GIFT75. The FAQ notes IVIM starts at $99 first month and $174/month ongoing in one place, and elsewhere the landing content lists the lower formulation prices noted above; both pricing references are included in the supplied material. He & She MD presents six-month introductory rates: semaglutide injections at $139/month introductory (regularly $199/month after six months) and tirzepatide at $199/month intro (regularly $289/month after six months). The He & She MD source stresses that headline prices are six-month promos that renew higher.

Comparison table: IVIM Health vs He & She MD

Criteria IVIM Health He & She MD
Third-party ratings 4.9 stars on Google and Trustpilot No dual 4.9-star rating cited in source
Consultation offer No-obligation free consult (a $75 value) Quick 2-3 minute intake to check eligibility; no payment required to check
Coaching and clinician access Clinician-guided GLP-1 ID protocol and weekly adjustments noted App with 1:1 clinician messaging, coaching and tracking included
Pricing model Compounded medication pricing listed (e.g., semaglutide $75/mo; tirzepatide $133/mo) plus $74.99 program fee; FAQ cites $99 first month and $174/mo ongoing Six-month introductory prices (e.g., semaglutide $139/mo intro; renews higher after six months)
Medication type Compounded semaglutide and tirzepatide; compounded drugs not FDA-approved Compounded semaglutide, tirzepatide; produced in USP-compliant state-regulated pharmacies and not reviewed by FDA
Shipping and fees Program fee noted; shipping and state availability cautions in source Free expedited shipping; no membership fee

Outcomes and evidence claims

IVIM Health cites internal and published-observational data: the source reports IVIM patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial, and IVIM claims its GLP-1 ID protocol can accelerate weight loss outcomes by up to 40%. The source explicitly qualifies these as not head-to-head trials and notes results may vary. He & She MD references self-reported retrospective figures and program messaging about weight loss but the supplied evidence calls those self-reported and not trial data. Neither provider claim is described as a randomized head-to-head clinical trial in the supplied material.

Regulatory and safety notes

Both sources include regulatory cautions: the IVIM material repeats that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. He & She MD also states that medications included are produced in USP-compliant, state-regulated pharmacies and are not reviewed by the FDA for safety, efficacy or quality. Each source says prescriptions are subject to clinician review and not all customers will qualify.

Explore He & She MD six-month promo pricing

Which differences matter most to you?

If third-party ratings and a free, no-obligation consult are highest priority, IVIM Health stands out with dual 4.9-star reviews and a free consultation plus a free month code. If built-in coaching, 1:1 clinician messaging and an app-first plan are most important, He & She MD bundles those features and highlights six-month introductory pricing that includes free expedited shipping and no separate membership fee.

See He & She MD app and clinician messaging plan

Bottom line and recommendation

IVIM Health vs He & She MD: IVIM offers unusually strong third-party ratings and a clinician-guided GLP-1 ID protocol with a free no-obligation consult and a free-month code. He & She MD focuses on bundled coaching with 1:1 messaging, progress tracking in an app and six-month promotional pricing that renews higher. Both use compounded GLP-1 medications and include clinician review and prescription requirements.

Choose IVIM Health if you value verified external ratings, want a free no-obligation $75 consult and prefer a clinician-guided GLP-1 ID protocol plus the GIFT75 free month membership code.

Choose He & She MD if you prefer a plan that includes a coaching app with 1:1 clinician messaging and progress tracking built in, along with six-month introductory pricing and free expedited shipping.

Ready to Compare Telehealth Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

More comparisons

Provider ReviewsJoinFridays vs IVIM Health: pricing, protocols, and outcomesJoinFridays starts at $117/month with compounded tirzepatide and semaglutide, no long-term contracts. IVIM Health offers a GIFT75 free month and dual 4.9-star ratings.September 9, 2026Provider ReviewsIVIM Health vs TMates: Pricing, Access, and Protocols ComparedIVIM Health offers a GIFT75 free month and compounded semaglutide from $75/mo and tirzepatide $133/mo; TMates is $199/month flat with 24/7 U.S. doctor access.September 9, 2026Provider ReviewsIVIM Health vs Telos Rx: Which Compounded GLP-1 Option Fits You?IVIM Health offers dual 4.9-star third-party ratings, a proprietary GLP-1 ID protocol and a free month code. Telos Rx advertises compounded semaglutide from $99 and tirzepatide from $139, subject to clinician approval.September 9, 2026Provider ReviewsStart Willow vs He & She MD: Pricing, Support, Shipping ComparedStart Willow: compounded semaglutide from $249 first month, $299/mo ongoing, 3-day delivery, no insurance. He & She MD: semaglutide from $139/mo intro with coaching.September 22, 2026Provider ReviewsSprout Health vs He & She MD: Fast Entry vs Built-In CoachingSprout Health offers fast, low-friction GLP-1 access with $50 off first month and claims 10–26% weight loss; He & She MD bundles coaching, messaging, and starter prices from $139.September 21, 2026Provider ReviewsSnagRx vs He & She MD: Price Lock vs Built-in CoachingSnagRx offers compounded semaglutide from $69/month on a 12-month plan with price locked at every dose. He & She MD bundles coaching from $139/month intro.September 20, 2026

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.